Łukasz Mazurek

Mr. Łukasz Mazurek

Medical University of Warsaw, Warsaw, Mazowieckie, Poland
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 December 2022 in Biomolecules
Verified
Journal Article
Open access
PDF file
ŁMŁukasz Mazurek
Łukasz Mazurek
MSMateusz Szudzik
Mateusz Szudzik
MRMateusz Rybka
Mateusz Rybka
Marek KonopMarek Konop
Marek Konop
The skin, acting as the outer protection of the human body, is most vulnerable to injury. Wound healing can often be impaired, leading to chronic, hard-to-heal wounds. For this reason, searching for the most effective dressings that can significantly enhance the wound healing process is necessary. In this regard, silk fibroin, a protein derived from silk fibres that has excellent properties, is noteworthy. Silk fibroin is highly biocompatible and biodegradable. It can easily make various dressings, which can be loaded with additional substances to improve healing. Dressings based on silk fibroin have anti-inflammatory, pro-angiogenic properties and significantly accelerate skin wound healing, even compared to commercially available wound dressings. Animal studies confirm the beneficial influence of silk fibroin in wound healing. Clinical research focusing on fibroin dressings is also promising. These properties make silk fibroin a remarkable natural material for creating innovative, simple, and effective dressings for skin wound healing. In this review, we summarise the application of silk fibroin biomaterials as wound dressings in full-thickness, burn, and diabetic wounds in preclinical and clinical settings.

26 December 2022 in Life
Verified
Journal Article
Open access
PDF file
MRMateusz Rybka
Mateusz Rybka
ŁMŁukasz Mazurek
Łukasz Mazurek
Marek KonopMarek Konop
Marek Konop
Impaired wound healing affects hundreds of million people around the world; therefore, chronic wounds are a major problem not only for the patient, but also for already overloaded healthcare systems. Chronic wounds are always very susceptible to infections. Billions of dollars are spent to discover new antibiotics as quickly as possible; however, bacterial resistance against antibiotics is rising even faster. For this reason, a complete shift of the antibacterial treatment paradigm is necessary. The development of technology has allowed us to rediscover well-known agents presenting antimicrobial properties with a better outcome. In this context, silver nanoparticles are a promising candidate for use in such therapy. Silver has many useful properties that can be used in the treatment of chronic wounds, such as anti-bacterial, anti-inflammatory, and anti-oxidative properties. In the form of nanoparticles, silver agents can work even more effectively and can be more easily incorporated into various dressings. Silver-based dressings are already commercially available; however, innovative combinations are still being discovered and very promising results have been described. In this review article, the authors focused on describing experimental and clinical studies exploring dressings containing either silver or silver nanoparticles, the results of which have been published in recent years.

8 April 2025 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
ŁMŁukasz Mazurek
Łukasz Mazurek
MKMonika Kuś
Monika Kuś
JJJan Jurak
Jan Jurak
MRMateusz Rybka
Mateusz Rybka
MKMarta Kuczeriszka
Marta Kuczeriszka
Marek KonopMarek Konop
Marek Konop

Verified
Journal Article
Open access
PDF file
MAMarta Aleksandrowicz
Marta Aleksandrowicz
Marek KonopMarek Konop
Marek Konop
MRMateusz Rybka
Mateusz Rybka
ŁMŁukasz Mazurek
Łukasz Mazurek
MSMonika Stradczuk-Mazurek
Monika Stradczuk-Mazurek
MKMarta Kuczeriszka
Marta Kuczeriszka
Cardiovascular diseases (CVDs) are the leading causes of death worldwide, and most of them are connected with atherosclerosis (AS). Hypertension (HT), hyperlipidemia (HPL), and hyperglycaemia (HG) are the main risk factors responsible for CVD and have become a significant public health issue. AS might be a prime causative factor in CVD, and it originates from endothelial cell dysfunction. On the other hand, the factors mentioned above might cause endothelial cell damage as a consequence of endothelial dysfunction (ED) or might be regarded as a consequence of ED. Thus, endothelial cells are critical for maintaining vascular health and homeostasis, and their function is a key contributor to the initiation and progression of AS. The autoregulation of microcirculation, which is functionally present in the brain and kidneys, and from the physiological and pathophysiological point of view, is of high importance to preserve the proper function of the endothelium of blood vessels. The key factor responsible for cardiovascular system regulation and proper action is nitric oxide (NO). Disturbances in NO synthesis and/or bioavailability, caused by oxidative stress and/or inflammation, accompany or even precede diseases such as HT, angiogenesis-associated disorders, HPL, and HG, which are on the pathway of AS development. In the present review, we attempted to synthesize recent advances in understanding the pathophysiology of multifactorial-related AS.

29 July 2024 in Macromolecular Bioscience
Verified
Journal Article
Closed access
ŁMŁukasz Mazurek
Łukasz Mazurek
MRMateusz Rybka
Mateusz Rybka
JJJan Jurak
Jan Jurak
JFJakub Frankowski
Jakub Frankowski
Marek KonopMarek Konop
Marek Konop

25 October 2022 in Journal of Natural Fibers
Verified
Journal Article
Open access
Marek KonopMarek Konop
Marek Konop
MRMateusz Rybka
Mateusz Rybka
MSMateusz Szudzik
Mateusz Szudzik
ŁMŁukasz Mazurek
Łukasz Mazurek
ALAnna Laskowska
Anna Laskowska
JCJoanna Czuwara
Joanna Czuwara
Impaired wound healing particularly in diabetics creates a significant healthcare burden. The study aimed to evaluate the effect of keratin-butyrate fibers (FKDP +0.1%NaBu) in a full-thickness skin wound model in 30 diabetic rats. Physicochemical examination showed that the obtained dressing possesses a heterogeneous structure and butyrate was slowly released into the wound. Moreover, the obtained dressing is nontoxic and supports cell growth. In vivo results showed that keratin-butyrate dressing accelerated wound healing on days 4 and 7 post-injury (p < .05). Histopathological and immunofluorescence examination revealed that applied dressing stimulated macrophage infiltration, which favors tissue remodeling and regeneration. The dressing was naturally incorporated into regenerating tissue. The highest mRNA expression level of interleukin 1β (IL-1β) was observed during the first 2 weeks in the control wounds compared to FKDP +0.1%NaBu treated wounds, in which IL-1β was significantly decreased. In FKDP +0.1%NaBu dressed wounds, mRNA expression of IL-10 and VEGF increased significantly (p < .05) from day 14. Keratin-butyrate treated wounds enhanced mRNA expression of keratin 16 and 17 and zonula occludens protein-1 and junctional adhesion molecules (p < .05) on days 14, 21, and 28 post-injuries. Our study showed that keratin butyrate dressing is safe and can efficiently accelerate skin wound healing in diabetic rats. GRAPHIC ABSTRACT